Life Sciences

  • July 19, 2019

    J&J Still Can't Transfer 2,400 Talc Suits To Del. Fed. Court

    Johnson & Johnson lost another bid to transfer 2,400 personal injury and wrongful death suits over allegedly contaminated talc powder products to Delaware federal court on Friday, when a judge found that the company failed to prove the case is "related to" its talc supplier's bankruptcy case.

  • July 19, 2019

    DOJ Tries To Push CVS-Aetna Deal Past Court Review

    The U.S. Department of Justice on Friday urged a D.C. federal judge to sign off on its settlement clearing CVS' purchase of Aetna, trying to rein in the scope of the court's review but facing resistance from the bench during oral arguments.

  • July 19, 2019

    Endo Pharma To Pay $2.3M To 18 States In Lidoderm Deal

    Endo Pharmaceuticals Inc. has agreed to pay $2.3 million to 18 states in a deal reached Friday, the same day the states hit the pharmaceutical company with a suit alleging it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch.

  • July 19, 2019

    Research Refutes J&J Talc Asbestos Claims, Jury Hears

    An attorney defending Johnson & Johnson against claims its talcum powder caused mesothelioma pressed an environmental health expert on Friday to acknowledge research to the contrary, highlighting for a New Jersey jury asbestos studies by scientists and the company’s sophisticated quality control and asbestos detection methods.

  • July 19, 2019

    'Everybody In The Crosshairs' As DOJ Opioid Blitz Gets Real

    The U.S. Department of Justice's newest indictment of a painkiller distributor and its executives strongly suggests that the agency has embarked on a calculated criminal crackdown after years of civil enforcement failed to ease the opioid epidemic.

  • July 19, 2019

    'Conspiracy' Claim Can't Save Antitrust Case, 7th Circ. Told

    The Seventh Circuit should reject attempts to cut the legs off a rule blocking indirect purchasers from suing a manufacturer for antitrust violations, the Washington Legal Foundation told the court, which is considering antitrust claims from buyers of syringes and catheters who think they were forced to pay too much.

  • July 19, 2019

    Massachusetts Cases To Watch: Midyear Report

    Boston courthouses have been hopping as spring has turned to summer and high-profile white collar cases, the anticipated verdict in a landmark education and employment case, and a pair of cases dealing with courthouse immigration arrests have been filling up the Bay State's dockets. Here, Law360 highlights some of the most important cases to watch in the second half of 2019.

  • July 19, 2019

    Goodwin Guides Radiology Biz To $4B Valuation

    Venture capital-backed Radiology Partners, guided by Goodwin, said Friday it reached a $4 billion valuation following an investment from Starr Investment Holdings.

  • July 19, 2019

    GSK Calls For Preemption Ruling In Zofran Birth Defect MDL

    GlaxoSmithKline has renewed its bid to end multidistrict litigation in Massachusetts federal court over claims it didn’t warn customers about alleged birth defects resulting from its anti-nausea medication, saying a recent Supreme Court ruling opens the way for the judge to rule the claims are preempted by federal law.

  • July 22, 2019

    Q&A With Skadden Mass Torts Leader John Beisner

    Skadden Arps Slate Meagher & Flom LLP's John Beisner — recently tapped by Bayer AG to advise the company on the ongoing litigation over its weedkiller Roundup — talked with Law360 about what changes he's seen in mass tort proceedings, his most challenging cases and his reflections on the passing of the late Justice John Paul Stevens.

  • July 19, 2019

    Ex-Merck Workers Get Green Light For $6.2M Sex Bias Deal

    A New Jersey federal judge signed off Friday on a $6.2 million settlement in a proposed class action against Merck & Co. Inc. over gender discrimination claims from female former sales representatives, saying the agreement is set to benefit roughly 3,000 class members.

  • July 19, 2019

    Former Congressman Peter Roskam Joins Sidley Austin

    Sidley Austin LLP has hired former U.S. Rep. Peter Roskam, R-Ill., to join the firm's government strategies group after 25 years serving in both state and national government.

  • July 18, 2019

    Stryker Slams Zimmer's High Court Bid Following $254M Loss

    Zimmer Inc.’s quest to see its $254 million surgical tool patent infringement loss reviewed by the U.S. Supreme Court is “predicated on a strawman argument” and “completely misses the point” of the high court’s 2016 ruling relaxing the standard for enhanced patent damages, Stryker Corp. told the Supreme Court on Thursday.

  • July 18, 2019

    Talc Left 'Fingerprint' In Ky. Travel Agent's Lungs, Jury Hears

    A Kentucky travel agent who died of mesothelioma had a signature mix of talc and asbestos in her lung tissue traceable to talcum powder, according to evidence presented Thursday in an unusual joint trial against manufacturers Johnson & Johnson and Colgate-Palmolive.

  • July 18, 2019

    Pfizer Wants Breast Cancer Drug MDL Consolidated In Del.

    Pfizer Inc. and its affiliates asked the U.S. Judicial Panel on Multidistrict Litigation Thursday to transfer a suit from West Virginia to Delaware, where 13 nearly identical federal complaints are pending that claim infringement of three drug patents central to a Pfizer breast cancer treatment.  

  • July 18, 2019

    Clark Hill Client Says Firm Pushed $1M Deal For His $63M Suit

    A Philadelphia-area mergers and acquisitions adviser said Clark Hill PLC attorneys pressured him into accepting a settlement worth less than $1 million for a $63.5 million lawsuit, according to a professional malpractice claim filed Wednesday in a Pennsylvania state court.

  • July 18, 2019

    CVS Says It's 'Impossible' To Tell Who's In Price-Gouging Suit

    CVS urged a Rhode Island federal judge not to certify classes of insured health plans claiming the company conspired with pharmacy benefits managers to overcharge them for generic drugs while secretly offering discounts to cash-paying customers, saying the fraud classes are undefinable.

  • July 18, 2019

    Pfizer Hid Risks Of Sepsis, Amputation On Labels, Suit Says

    An Arkansas woman sued Pfizer Inc. on Thursday, saying the company failed to warn U.S. customers that an arthritis drug can cause sepsis, resulting in the amputation of all four of her limbs, while European labels of the same drug contain such warnings.

  • July 18, 2019

    Tax Court Hewed Too Closely To CUT In Medtronic, Atty Says

    The U.S. Tax Court would have been better served by a looser interpretation of the comparable uncontrolled transaction method in the Medtronic case, tax specialists who examined the use of different methods in transfer pricing cases said Thursday.

  • July 18, 2019

    Ill. Latest Battleground For Bayer In Essure Safety Suits

    Bayer Corp. has been hit with a lawsuit in Illinois state court claiming the company misrepresented the safety of its Essure permanent birth control device and hid its serious and potentially life-threatening risks in women.

  • July 18, 2019

    5 Cos. Price IPOs Totaling $1.1B, Led By Danish Biotech Firm

    Five companies’ shares began trading on U.S. exchanges Thursday after the companies, led by a Danish biotechnology firm, priced initial public offerings that together raised nearly $1.1 billion.

  • July 18, 2019

    Texas Firms Aim To Dodge NJ Pelvic Mesh Malpractice Suit

    Potts Law Firm and other Texas firms accused of improperly pocketing excessive attorney fees from roughly 1,450 pelvic mesh victims have asked a New Jersey federal court to toss a proposed class action against them, arguing the plaintiff didn't actually "sustain any damages."

  • July 18, 2019

    DOJ Indicts Opioid Distributor, Execs Over Painkiller Sales

    Drug distributor Miami-Luken Inc. flooded rural towns with painkillers to profit off an epidemic of opioid addiction, the U.S. Department of Justice said in an indictment unsealed Thursday that targets the company and two of its executives.

  • July 18, 2019

    Drugmakers Tell 7th Circ. Insurer's Testosterone Suit Flawed

    A group of pharmaceutical companies is urging the Seventh Circuit not to revive a suit by Medical Mutual of Ohio that accused them of running a conspiracy to hide the harmful effects of testosterone supplements, saying the insurer never showed how it relied on their alleged misrepresentations.

  • July 18, 2019

    Martin Shkreli's Conviction Upheld By 2nd Circ.

    The Second Circuit on Thursday affirmed the conviction of notorious former pharmaceutical executive Martin Shkreli on securities fraud and conspiracy charges, saying there was no error in the jury instructions at his trial.

Expert Analysis

  • 4 Things FTC Competition Bureau Looks For In White Papers

    Author Photo

    Most written advocacy to the Bureau of Competition is of an extremely high quality, but sometimes we notice that there’s some room for improvement, says Daniel Francis, an associate director at the Federal Trade Commission's Bureau of Competition.

  • Preinstitution Submissions May Limit Certain ITC Probes

    Author Photo

    Following recent rule changes, U.S. International Trade Commission determinations and decisions by the Federal Circuit, proposed respondents may be able to prevent or limit the scope of ITC Section 337 investigations if they act quickly using various types of preinstitution submissions, says Michael Doane of Miles & Stockbridge.

  • Remembering Justice Stevens As A Law Firm Leader

    Author Photo

    Rothschild Barry's John Coffey, who joined Justice John Paul Stevens' law firm in 1965, shares what it was like to watch Justice Stevens practice law, mentor younger lawyers and land a malfunctioning plane.

  • A New Era For Human Genetic Resource Compliance In China

    Author Photo

    This month, China's new regulations governing the management of human genetic resources came into effect, bringing stronger enforcement measures and much heavier liabilities that will require many companies, medical and research institutions, and universities to upgrade their compliance systems accordingly, say attorneys at Tian Yuan.

  • Calif. Privacy Law's 3 Limited Exemptions For Health Cos.

    Author Photo

    So that health and life sciences companies can better determine whether the information they collect is subject to the California Consumer Privacy Act, Jason Linder and Libby Jelinek of Irell & Manella address the scope of certain CCPA exemptions and identify the main areas of ambiguity.

  • What High Court's Kisor Ruling Means For FDA Decisions

    Author Photo

    The U.S. Supreme Court's decision in Kisor v. Wilkie, weakening Auer deference, gives courts more authority to challenge agency decisions — even those concerning very technical regulations, as many of the U.S. Food and Drug Administration's do, say attorneys at Axinn.

  • Answers To Key Legal Finance Ethics Questions

    Author Photo

    While there is discussion in some quarters about new regulations on commercial legal finance, the hands-off approach taken by the majority of courts and legislatures is an implicit recognition that it is already sufficiently regulated, says Danielle Cutrona of Burford Capital.

  • Preemption Vs. Public Nuisance, In Aviation And Opioids

    Author Photo

    A recent Iowa Supreme Court ruling concerning a local airport commission's authority to condemn a structure declared safe by the Federal Aviation Administration presents many of the same preemption questions that will play out in opioid litigation, says Richard Dean of Tucker Ellis.

  • Federal Agencies Need A Uniform Record-Keeping Process

    Author Photo

    The administrative record is very important to federal agency litigation — as showcased in last month's U.S. Supreme Court decision concerning the addition of a citizenship question to the 2020 census — yet there is no set of consistent principles to guide agencies in compiling these official records, say attorneys at WilmerHale.

  • The Role Of Dictionaries In Last Term's High Court Decisions

    Author Photo

    Since 32 of the 67 decisions issued by the U.S. Supreme Court during its October term cite dictionaries, it’s worth reviewing the opinions to learn which dictionaries the justices consulted and how they used them, say Bruce Wessel and Brian Weissenberg of Irell & Manella.

  • How To Evaluate The Rise In Legal Employment

    Author Photo

    Although the rate of employment for law school graduates — which had been falling steadily — saw a small increase over the last year, other factors, such as fewer graduates overall and potential future job growth stagnation, temper the good news for those pursuing law degrees, say Tiffane Cochran and Tyler Grimm of AccessLex Institute.

  • Tips For Patenting And Protecting Wearable Technology

    Author Photo

    The approach to patents practiced by fashion brands needs to evolve as technology’s integration into fashion becomes more frequent and complex, says Barry Lewin of Gottlieb Rackman.

  • Foreign Investment In US Biotech Gets Greater Gov't Scrutiny

    Author Photo

    Chinese investment in the U.S. biotech industry is attracting increased government oversight, as evidenced by the Committee on Foreign Investment in the United States blocking several such transactions in the last 16 months. Two important proposed rules could materially affect the industry further, say attorneys at Morgan Lewis.

  • Biosimilar Patent Litigation Bill Would Change BPCIA Strategy

    Author Photo

    If passed, the Affordable Prescriptions for Patients Act will limit the number of patents that can be raised in litigation under the Biologics Price Competition and Innovation Act, with significant repercussions for biosimilar applicants deciding whether to engage in a patent dance, say attorneys at Paul Hastings.

  • Opinion

    The Business Case For Championing Diverse Legal Teams

    Author Photo

    Leveraging the collective strengths of a diverse workforce is not only the right thing to do, it’s a strategic imperative for any successful firm or business, says Louise Pentland, executive vice president and chief business affairs and legal officer of PayPal.